sestamibi

(redirected from Cardiolite)
Also found in: Dictionary.

sestamibi

(sĕs′tə-mē′bē)
n.
An injectable drug containing an isotope of the radioactive element technetium, used in nuclear medicine imaging primarily to visualize the heart muscle, parathyroid glands, and breast tissue.

sestamibi

99mTc or technicium-99m sestamibi Imaging A myocardial perfusion agent for assessing an 'at-risk' myocardium–for acute MI, used with tomography to determine the final size of an acute MI
References in periodicals archive ?
Transaxial FLAIR MR images show raw data images from the initial imaging, a Cardiolite (technetium Tc99m sestamibi) exam, demonstrated a subtle region of abnormally increased activity in the left breast (Figure 1).
As the end of the patent for Cardiolite drew near, the agency was tasked to revitalize the brand by giving it a "launch" look and feel--as well as help Cardiolite continue to maintain its dominant share of the market in the face of growing competition.
Syncor will increase the price of both unit dose and bulk Cardiolite and Miraluma (sestamibi).
sestamibi, CardioLite, Lantheus Medical Imaging, North Billerica, MA; and, tetrofosmin, Myoview, GE Healthcare, Chalfont St.
Bermuda-based Covidien won tentative approval for its generic version of Bristol-Myers Squibb Co.'s Cardiolite, an imaging agent used in cardiac stress tests.
It is funded by Bristol-Myers Squibb Medical Imaging Inc., manufacturer of the radioactive dye Cardiolite, and by Fujisawa Healthcare Inc., maker of Adenoscan, a vasodilator stressing agent.
The study is funded by Bristol-Myers Squibb Medical Imaging Inc., maker of the radioactive dye Cardiolite, and Fujisawa Healthcare Inc., maker of Adenoscan, a vasodilator stressing agent.
DuPont brings a number of new products to the table, including Sustiva (for HIV/AIDS), Coumadin (a blood anticoagulant) and Cardiolite (a cardiovascular imaging agent).
Last year DuPont's drug division generated sales of $1.5 billion, led by such products as Sustiva, Coumadin and Cardiolite.
DuPont also continues to hold solid competitive positions with such drugs as Sustiva, a market-leading therapy to treat HIV; Coumadin, an oral anticoagulant; and Cardiolite, a nuclear cardiology imaging agent.
Some of Du Pont Merck's best-known commercial drugs are Coumadin, an oral anticoagulant; Sinemet/CR, a treatment for Parkinson's disease; ReVia, a treatment for alcohol dependency; and Cardiolite, a heart-imaging agent.